Clinical Trial Update: A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) [Phase 3]

View source ↗

Summary

This document provides a Phase 3 trial update for obexelimab in warm autoimmune hemolytic anemia, noting that the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Obexelimab (obexelimab)

Snippet

Sponsor: Zenas BioPharma (USA), LLC | Conditions: Warm Autoimmune Hemolytic Anemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING